Immunovia AB (publ) (IMMVF)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.00 SEK | -100.0% |
| 2022 | 2.01 Million SEK | -6.23% |
| 2021 | 2.15 Million SEK | -61.35% |
| 2020 | 5.56 Million SEK | 7.14% |
| 2019 | 5.19 Million SEK | -54.63% |
| 2018 | 11.44 Million SEK | 908.96% |
| 2017 | -1.41 Million SEK | -186.85% |
| 2016 | 1.62 Million SEK | 1257.8% |
| 2015 | -140.68 Thousand SEK | 0.0% |
| 2014 | - SEK | 0.0% |
| 2013 | - SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - SEK | -100.0% |
| 2024 Q2 | -5.6 Million SEK | 0.0% |
| 2023 Q3 | -539.44 Thousand SEK | -8.79% |
| 2023 FY | 1.00 SEK | -100.0% |
| 2023 Q2 | -495.87 Thousand SEK | -121.18% |
| 2023 Q1 | 2.34 Million SEK | 16.12% |
| 2023 Q4 | 1.00 SEK | 100.0% |
| 2022 Q3 | 1.27 Million SEK | -20.24% |
| 2022 FY | 2.01 Million SEK | -6.23% |
| 2022 Q1 | 1.53 Million SEK | -28.42% |
| 2022 Q2 | 1.59 Million SEK | 3.7% |
| 2022 Q4 | 2.01 Million SEK | 58.37% |
| 2021 Q1 | - SEK | 0.0% |
| 2021 FY | 2.15 Million SEK | -61.35% |
| 2021 Q4 | 2.15 Million SEK | 63.87% |
| 2021 Q3 | 1.31 Million SEK | -33.94% |
| 2021 Q2 | 1.98 Million SEK | 3331955097600100.0% |
| 2020 Q3 | - SEK | -100.0% |
| 2020 Q1 | - SEK | 0.0% |
| 2020 Q4 | - SEK | 0.0% |
| 2020 FY | 5.56 Million SEK | 7.14% |
| 2020 Q2 | - SEK | 0.0% |
| 2019 Q1 | - SEK | -100.0% |
| 2019 Q4 | - SEK | 0.0% |
| 2019 Q2 | - SEK | 0.0% |
| 2019 FY | 5.19 Million SEK | -54.63% |
| 2019 Q3 | - SEK | 0.0% |
| 2018 Q4 | 1.00 SEK | 0.0% |
| 2018 FY | 11.44 Million SEK | 908.96% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q1 | - SEK | 0.0% |
| 2018 Q2 | - SEK | 0.0% |
| 2017 Q2 | - SEK | 0.0% |
| 2017 FY | -1.41 Million SEK | -186.85% |
| 2017 Q4 | - SEK | 0.0% |
| 2017 Q3 | - SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2016 Q2 | - SEK | 0.0% |
| 2016 FY | 1.62 Million SEK | 1257.8% |
| 2016 Q1 | - SEK | 0.0% |
| 2016 Q4 | - SEK | 0.0% |
| 2015 Q1 | - SEK | 0.0% |
| 2015 Q2 | - SEK | 0.0% |
| 2015 Q4 | - SEK | 0.0% |
| 2015 Q3 | - SEK | 0.0% |
| 2015 FY | -140.68 Thousand SEK | 0.0% |
| 2014 Q1 | - SEK | 0.0% |
| 2014 Q4 | - SEK | 0.0% |
| 2014 Q3 | - SEK | 0.0% |
| 2014 FY | - SEK | 0.0% |
| 2013 FY | - SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | 100.0% |
| Arrayit Corporation | 464.19 Thousand USD | 100.0% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | 100.0% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 100.042% |
| DermTech, Inc. | 1 Million USD | 100.0% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 100.0% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | 100.0% |
| iMD Companies, Inc. | 38.31 Thousand USD | 99.997% |
| IDenta Corp. | 442.28 Thousand USD | 100.0% |
| Interpace Biosciences, Inc. | 1.22 Million USD | 100.0% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 163.13 Thousand USD | 99.999% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | 100.0% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 100.267% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | 100.0% |
| PharmChem, Inc. | 391.93 Thousand USD | 100.0% |
| Proteome Sciences plc | 1.06 Million USD | 100.0% |
| Response Genetics, Inc | 133 Thousand USD | 99.999% |
| Rennova Health, Inc. | 242.64 Thousand USD | 100.0% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | 99.999% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | 99.999% |
| Todos Medical Ltd. | 1.02 Million USD | 100.0% |